Article info
PDFCase Reports: Rare disease
Macular neovascularisation in a patient with osteogenesis imperfecta exhibiting a novel COL1A1 mutation
- Correspondence to Dr Kenichi Kimoto; kimotok{at}oita-u.ac.jp
Citation
Macular neovascularisation in a patient with osteogenesis imperfecta exhibiting a novel COL1A1 mutation
Publication history
- Accepted October 18, 2022
- First published November 7, 2022.
Online issue publication
November 07, 2022
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© BMJ Publishing Group Limited 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.